Cargando…

Risk of infections and their role on subsequent mortality in biopsy‐proven alcohol‐related liver disease

BACKGROUND AND AIMS: The risk for infection in alcohol‐related liver disease (ALD) has rarely been investigated at a population level, nor if the underlying liver histopathology is associated with infection risk. We examined the rate of hospital‐based infections in a nationwide cohort of biopsy‐prov...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagström, Hannes, Thiele, Maja, Simon, Tracey G., Sharma, Rajani, Röckert Tjernberg, Anna, Roelstraete, Bjorn, Söderling, Jonas, Ludvigsson, Jonas F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911538/
https://www.ncbi.nlm.nih.gov/pubmed/35088575
http://dx.doi.org/10.1002/ueg2.12200
_version_ 1784666837431091200
author Hagström, Hannes
Thiele, Maja
Simon, Tracey G.
Sharma, Rajani
Röckert Tjernberg, Anna
Roelstraete, Bjorn
Söderling, Jonas
Ludvigsson, Jonas F.
author_facet Hagström, Hannes
Thiele, Maja
Simon, Tracey G.
Sharma, Rajani
Röckert Tjernberg, Anna
Roelstraete, Bjorn
Söderling, Jonas
Ludvigsson, Jonas F.
author_sort Hagström, Hannes
collection PubMed
description BACKGROUND AND AIMS: The risk for infection in alcohol‐related liver disease (ALD) has rarely been investigated at a population level, nor if the underlying liver histopathology is associated with infection risk. We examined the rate of hospital‐based infections in a nationwide cohort of biopsy‐proven ALD, and the subsequent risk of death. METHODS: Population‐based cohort study in Sweden comparing 4028 individuals with an international classification of disease (ICD) code for ALD and a liver biopsy from 1969 to 2017 with 19,296 matched general population individuals. Swedish national registers were used to ascertain incident infections in secondary or tertiary care and subsequent mortality until 2019. We used Cox regression, adjusted for sex, age, education, country of birth, diabetes, and number of hospitalizations in the year preceding liver biopsy date, to estimate hazard ratios (HRs) in ALD and histopathological subgroups compared to reference individuals. RESULTS: Median age at ALD diagnosis was 59 years, 65% were men and 59% had cirrhosis at baseline. Infections were more common in patients with ALD (84 cases/1000 person‐years [PY]) compared to reference individuals (29/1000 PYs; adjusted hazard ratio [aHR] 3.06, 95% CI = 2.85–3.29). This excess risk corresponded to one additional infection per 18 ALD patients each year. The rate of infections was particularly high in individuals with cirrhosis (aHR = 3.46) and in those with decompensation (aHR = 5.20). Restricting our data to those with an infection, ALD (aHR = 3.63, 95%CI = 3.36–3.93), and especially ALD cirrhosis (aHR = 4.31, 95%CI = 3.89–4.78) were linked to subsequent death. CONCLUSIONS: Individuals with biopsy‐proven ALD have a three‐fold increased rate of infections compared with the general population. The risk of death after an infection is also considerably higher in individuals with ALD.
format Online
Article
Text
id pubmed-8911538
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89115382022-03-17 Risk of infections and their role on subsequent mortality in biopsy‐proven alcohol‐related liver disease Hagström, Hannes Thiele, Maja Simon, Tracey G. Sharma, Rajani Röckert Tjernberg, Anna Roelstraete, Bjorn Söderling, Jonas Ludvigsson, Jonas F. United European Gastroenterol J Hepatobiliary BACKGROUND AND AIMS: The risk for infection in alcohol‐related liver disease (ALD) has rarely been investigated at a population level, nor if the underlying liver histopathology is associated with infection risk. We examined the rate of hospital‐based infections in a nationwide cohort of biopsy‐proven ALD, and the subsequent risk of death. METHODS: Population‐based cohort study in Sweden comparing 4028 individuals with an international classification of disease (ICD) code for ALD and a liver biopsy from 1969 to 2017 with 19,296 matched general population individuals. Swedish national registers were used to ascertain incident infections in secondary or tertiary care and subsequent mortality until 2019. We used Cox regression, adjusted for sex, age, education, country of birth, diabetes, and number of hospitalizations in the year preceding liver biopsy date, to estimate hazard ratios (HRs) in ALD and histopathological subgroups compared to reference individuals. RESULTS: Median age at ALD diagnosis was 59 years, 65% were men and 59% had cirrhosis at baseline. Infections were more common in patients with ALD (84 cases/1000 person‐years [PY]) compared to reference individuals (29/1000 PYs; adjusted hazard ratio [aHR] 3.06, 95% CI = 2.85–3.29). This excess risk corresponded to one additional infection per 18 ALD patients each year. The rate of infections was particularly high in individuals with cirrhosis (aHR = 3.46) and in those with decompensation (aHR = 5.20). Restricting our data to those with an infection, ALD (aHR = 3.63, 95%CI = 3.36–3.93), and especially ALD cirrhosis (aHR = 4.31, 95%CI = 3.89–4.78) were linked to subsequent death. CONCLUSIONS: Individuals with biopsy‐proven ALD have a three‐fold increased rate of infections compared with the general population. The risk of death after an infection is also considerably higher in individuals with ALD. John Wiley and Sons Inc. 2022-01-28 /pmc/articles/PMC8911538/ /pubmed/35088575 http://dx.doi.org/10.1002/ueg2.12200 Text en © 2022 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Hepatobiliary
Hagström, Hannes
Thiele, Maja
Simon, Tracey G.
Sharma, Rajani
Röckert Tjernberg, Anna
Roelstraete, Bjorn
Söderling, Jonas
Ludvigsson, Jonas F.
Risk of infections and their role on subsequent mortality in biopsy‐proven alcohol‐related liver disease
title Risk of infections and their role on subsequent mortality in biopsy‐proven alcohol‐related liver disease
title_full Risk of infections and their role on subsequent mortality in biopsy‐proven alcohol‐related liver disease
title_fullStr Risk of infections and their role on subsequent mortality in biopsy‐proven alcohol‐related liver disease
title_full_unstemmed Risk of infections and their role on subsequent mortality in biopsy‐proven alcohol‐related liver disease
title_short Risk of infections and their role on subsequent mortality in biopsy‐proven alcohol‐related liver disease
title_sort risk of infections and their role on subsequent mortality in biopsy‐proven alcohol‐related liver disease
topic Hepatobiliary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911538/
https://www.ncbi.nlm.nih.gov/pubmed/35088575
http://dx.doi.org/10.1002/ueg2.12200
work_keys_str_mv AT hagstromhannes riskofinfectionsandtheirroleonsubsequentmortalityinbiopsyprovenalcoholrelatedliverdisease
AT thielemaja riskofinfectionsandtheirroleonsubsequentmortalityinbiopsyprovenalcoholrelatedliverdisease
AT simontraceyg riskofinfectionsandtheirroleonsubsequentmortalityinbiopsyprovenalcoholrelatedliverdisease
AT sharmarajani riskofinfectionsandtheirroleonsubsequentmortalityinbiopsyprovenalcoholrelatedliverdisease
AT rockerttjernberganna riskofinfectionsandtheirroleonsubsequentmortalityinbiopsyprovenalcoholrelatedliverdisease
AT roelstraetebjorn riskofinfectionsandtheirroleonsubsequentmortalityinbiopsyprovenalcoholrelatedliverdisease
AT soderlingjonas riskofinfectionsandtheirroleonsubsequentmortalityinbiopsyprovenalcoholrelatedliverdisease
AT ludvigssonjonasf riskofinfectionsandtheirroleonsubsequentmortalityinbiopsyprovenalcoholrelatedliverdisease